These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 4391663)

  • 41. Normal myocardial adenyl cyclase activity in hyperthyroid cats.
    Sobel BE; Dempsey PJ; Cooper T
    Proc Soc Exp Biol Med; 1969 Oct; 132(1):6-9. PubMed ID: 4310179
    [No Abstract]   [Full Text] [Related]  

  • 42. Studies on the activation of phosphorylase in skeletal muscle by contraction and by epinephrine.
    Drummond GI; Harwood JP; Powell CA
    J Biol Chem; 1969 Aug; 244(15):4235-40. PubMed ID: 4308172
    [No Abstract]   [Full Text] [Related]  

  • 43. Influence of hyperthyroidism on the effects of norepinephrine on myocardial adenyl cyclase activity and contractile state.
    Levey GS; Skelton CL; Epstein SE
    Endocrinology; 1969 Dec; 85(6):1004-9. PubMed ID: 4310483
    [No Abstract]   [Full Text] [Related]  

  • 44. Kinetics of cyclic adenosine monophosphate changes in rat heart following epinephrine administration.
    Cheung WY; Williamson JR
    Nature; 1965 Aug; 207(5000):979-81. PubMed ID: 5886938
    [No Abstract]   [Full Text] [Related]  

  • 45. Role of glucagon and adrenergic receptors in thyrocalcitonin release in the dog.
    Avioli LV; Shieber W; Kipnis DM
    Endocrinology; 1971 Jun; 88(6):1337-40. PubMed ID: 4324677
    [No Abstract]   [Full Text] [Related]  

  • 46. Epinephrine- and glucagon-stimulated cardiac adenylyl cyclase activity. Regulation by endogenous factors.
    Sanders RB; Thompson WJ; Robison GA
    Biochim Biophys Acta; 1977 Jun; 498(1):10-20. PubMed ID: 884141
    [No Abstract]   [Full Text] [Related]  

  • 47. Cardiostimulatory effects of cyclic 3',5'-adenosine monophosphate and its acylated derivatives.
    Kukovetz WR; Pöch G
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(3):236-54. PubMed ID: 4316610
    [No Abstract]   [Full Text] [Related]  

  • 48. [Adenyl-cyclase system in the distribution of energy].
    Assan R
    Pathol Biol (Paris); 1970 May; 18(9):489-97. PubMed ID: 4316193
    [No Abstract]   [Full Text] [Related]  

  • 49. Requirement of Ca ion for the stimulating effect of cyclic 3',5'-AMP on muscle phosphorylase b kinase.
    Ozawa E; Ebashi S
    J Biochem; 1967 Aug; 62(2):285-6. PubMed ID: 5586495
    [No Abstract]   [Full Text] [Related]  

  • 50. The role of cyclic 3'5'-AMP in the cardiac response to adrenaline.
    Oye I; Langslet A
    Acta Pharmacol Toxicol (Copenh); 1970; 28(1):93. PubMed ID: 4325963
    [No Abstract]   [Full Text] [Related]  

  • 51. Metabolic regulation of the response of the glycogen phosphorylase system to hormones in rat heart and diaphragm.
    Horn RS; Hostmark AT
    Acta Endocrinol Suppl (Copenh); 1974; 191():81-92. PubMed ID: 4375384
    [No Abstract]   [Full Text] [Related]  

  • 52. Evidence against a requirement for phospholipid methylation in adenylate cyclase activation by hormones. Methyltransferase inhibitors do not impair cyclic AMP accumulation induced by glucagon or beta-adrenergic agents in rat hepatocytes.
    Schanche JS; Ogreid D; Døskeland SO; Refsnes M; Sand TE; Ueland PM; Christoffersen T
    FEBS Lett; 1982 Feb; 138(2):167-72. PubMed ID: 6279442
    [No Abstract]   [Full Text] [Related]  

  • 53. Evidence that cyclic AMP is not involved in the chronotropic action of glucagon in the adult mouse heart.
    Clark CM
    Endocrinology; 1976 Jul; 99(1):23-9. PubMed ID: 181238
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Platelet phosphorylase activity in the presence of activators and inhibitors of aggregation.
    Deisseroth A; Wolfe SM; Shulman NR
    Biochem Biophys Res Commun; 1970 Jul; 40(1):551-7. PubMed ID: 4318585
    [No Abstract]   [Full Text] [Related]  

  • 55. Evidence for delayed development of the glucagon receptor of adenylate cyclase in the fetal and neonatal rat heart.
    Clark CM; Beatty B; Allen DO
    J Clin Invest; 1973 May; 52(5):1018-25. PubMed ID: 4349483
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evidence for a role of cyclic AMP in the release of calcitonin.
    Care AD; Bates RF; Gitelman HJ
    Ann N Y Acad Sci; 1971 Dec; 185():317-26. PubMed ID: 4330497
    [No Abstract]   [Full Text] [Related]  

  • 57. Adenyl cyclase activity in rat liver nuclei.
    Soifer D; Hechter O
    Biochim Biophys Acta; 1971; 230(3):539-42. PubMed ID: 4325679
    [No Abstract]   [Full Text] [Related]  

  • 58. [Cardiovascular effects of glucagon].
    Liakishev AA; Golikov AP
    Kardiologiia; 1972 Jul; 12(7):128-36. PubMed ID: 4364203
    [No Abstract]   [Full Text] [Related]  

  • 59. Increased heart adenylcyclase activity in the hypothyroid rat.
    Broekhuysen J; Ghislain M
    Biochem Pharmacol; 1972 May; 21(10):1493-500. PubMed ID: 4337704
    [No Abstract]   [Full Text] [Related]  

  • 60. Subunit phosphorylation and activation of phosphorylase kinase in perfused rat hearts.
    Angelos KL; Ramachandran C; Walsh DA
    J Biol Chem; 1987 Mar; 262(7):3219-26. PubMed ID: 3029104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.